For the Inventor, By the Inventor

Enter assignee name

Campbell, CA, United States of America

Vivus, Inc.

USPTO Granted Patents = 45

CIPO Patents = 21

EPO Patents = 10

Trademarks = 26

Forward Citations = 1,428

Loading Chart...

Loading Chart...

32 inventors (with patents filed for the assignee):

Virgil A Place (24 out of 50 patents)

Leland F Wilson (16 out of 18 patents)

Paul C Doherty, Jr (13 out of 16 patents)

4. Thomas Najarian (12 out of 12 patents)

5. Peter Y Tam (10 out of 10 patents)

6. William L Smith (8 out of 8 patents)

7. Neil Gesundheit (7 out of 14 patents)

8. Mark S Hanamoto (6 out of 9 patents)

9. Alfred P Spivack (5 out of 7 patents)

10. Sean R Bennett (5 out of 8 patents)

11. Randall G Berggren (4 out of 11 patents)

12. Robert M Gale (4 out of 73 patents)

13. Wesley Day (2 out of 2 patents)

14. Barbara Troupin (2 out of 2 patents)

15. Craig Peterson (2 out of 2 patents)

45 patents: Sort by Forward Citations

1. 10058532 - Methods of preventing progression to type 2 diabetes mellitus (2018-08-28),

2. 10028916 - Orally disintegrating dosage form for administration of avanafil, and associated methods of manufacture and use (2018-07-24),

3. 9724327 - Methods of preventing progression to type 2 diabetes mellitus (2017-08-08),

4. 9011906 - Escalating dosing regimen for effecting weight loss and treating obesity (2015-04-21),

5. 9011905 - Low dose topiramate/phentermine composition and methods of use thereof (2015-04-21),

6. 8895058 - Low dose topiramate/phentermine composition and methods of use thereof (2014-11-25),

7. 8895057 - Escalating dosing regimen for effecting weight loss and treating obesity (2014-11-25),

8. 8802636 - Combination therapy for treatment of sleep apnea (2014-08-12),

9. 8580299 - Escalating dosing regimen for effecting weight loss and treating obesity (2013-11-12),

10. 8580298 - Low dose topiramate/phentermine composition and methods of use thereof (2013-11-12),

11. 8536138 - Treatment of pulmonary hypertension with carbonic anhydrase inhibitors (2013-09-17),

12. 8440671 - Compositions comprising a phoshodiesterase-5 inhibitor and their use in methods of treatment (2013-05-14),

13. 8071557 - Treatment of pulmonary hypertension with carbonic anhydrase inhibitors (2011-12-06),

14. 7674776 - Combination therapy for effecting weight loss and treating obesity (2010-03-09),

15. 7659256 - Combination therapy for effecting weight loss and treating obesity (2010-02-09),

Vivus, Inc. is a biopharmaceutical company specializing in the development and commercialization of novel therapeutic products. The company's focus is on the treatment of obesity, sleep apnea, and erectile dysfunction. Vivus is known for its innovative approach and commitment to improving patients' quality of life through effective, safe, and non-invasive medications.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

45 Patents

#12 in Campbell, CA

#1,777 in California

#7,493 in US

#14,962 in the World

Campbell, CA, United States of America

Vivus, Inc.

Forward Citations = 1,428

32 inventors:

Virgil A Place (24 out of 50 patents)

Leland F Wilson (16 out of 18 patents)

Paul C Doherty, Jr (13 out of 16 patents)

4. Thomas Najarian (12 out of 12 patents)

5. Peter Y Tam (10 out of 10 patents)

Please report any incorrect information to support@idiyas.com

Loading…